SAVA Cassava Sciences Inc
Price (delayed)
$1.39
Market cap
$67.15M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.53
Enterprise value
-$61.43M
Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to
Highlights
The quick ratio is up by 28% year-on-year
Cassava Sciences's EPS has soared by 77% YoY but it has decreased by 43% from the previous quarter
The net income has soared by 75% YoY but it has contracted by 38% from the previous quarter
Key stats
What are the main financial stats of SAVA
Market
Valuations
Earnings
Shares outstanding
48.31M
Market cap
$67.15M
Enterprise value
-$61.43M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.46
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$141.45M
Net income
-$24.34M
EBIT
-$24.34M
EBITDA
-$23.21M
Free cash flow
-$117.03M
Per share
Balance sheet
Liquidity
EPS
-$0.53
EPS diluted
-$1.46
Free cash flow per share
-$2.53
Book value per share
$3.03
Revenue per share
$0
TBVPS
$3.4
Total assets
$157.53M
Total liabilities
$11.83M
Debt
$0
Equity
$145.7M
Working capital
$124.78M
Debt to equity
0
Current ratio
11.62
Quick ratio
10.94
Net debt/EBITDA
5.54
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-12.5%
Return on equity
-16.8%
Return on invested capital
N/A
Return on capital employed
-16.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SAVA stock price
How has the Cassava Sciences stock price performed over time
Intraday
0.72%
1 week
-20.57%
1 month
-42.08%
1 year
-92.95%
YTD
-41.1%
QTD
-7.33%
Financial performance
How have Cassava Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$141.45M
Net income
-$24.34M
Gross margin
N/A
Net margin
N/A
The net income has soared by 75% YoY but it has contracted by 38% from the previous quarter
Cassava Sciences's operating income has decreased by 33% YoY and by 5% from the previous quarter
Growth
What is Cassava Sciences's growth rate over time
Valuation
What is Cassava Sciences stock price valuation
P/E
N/A
P/B
0.46
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Cassava Sciences's EPS has soared by 77% YoY but it has decreased by 43% from the previous quarter
SAVA's P/B is 93% below its 5-year quarterly average of 6.5 and 92% below its last 4 quarters average of 5.9
Cassava Sciences's equity has decreased by 13% from the previous quarter but it has increased by 6% YoY
Efficiency
How efficient is Cassava Sciences business performance
Cassava Sciences's ROA has soared by 76% YoY but it has decreased by 37% from the previous quarter
SAVA's return on equity has surged by 71% year-on-year but it is down by 35% since the previous quarter
Dividends
What is SAVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SAVA.
Financial health
How did Cassava Sciences financials performed over time
SAVA's total liabilities has plunged by 79% from the previous quarter and by 17% YoY
The total assets has decreased by 30% from the previous quarter but it has increased by 3.9% YoY
Cassava Sciences's debt is 100% less than its equity
Cassava Sciences's equity has decreased by 13% from the previous quarter but it has increased by 6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.